Exagen inc. to participate in the canaccord genuity 41st annual growth conference

San diego, july 29, 2021 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the canaccord genuity 41st annual growth conference, which takes place august 10-12, 2021. ron rocca, exagen's president and chief executive officer, and kamal adawi, chief financial officer, will participate in a virtual fireside chat on thursday, august 12 at 12:00 pm est.
XGN Ratings Summary
XGN Quant Ranking